Venus Concept Files S-1/A for Continuous Offering
Ticker: VERO · Form: S-1/A · Filed: Jul 24, 2025 · CIK: 1409269
| Field | Detail |
|---|---|
| Company | Venus Concept Inc. (VERO) |
| Form Type | S-1/A |
| Filed Date | Jul 24, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: S-1/A, Equity Offering, Medical Devices, Capital Raise, SEC Filing, Smaller Reporting Company, Rule 415
Related Tickers: VERO
TL;DR
**VERO is prepping for future capital raises, signaling potential dilution ahead for investors.**
AI Summary
Venus Concept Inc. (VERO) filed an S-1/A on July 24, 2025, for a delayed or continuous offering of securities under Rule 415, indicating a strategic move to secure future capital. The filing does not contain updated financial figures for revenue or net income, but it highlights the company's ongoing need for flexible financing. As a smaller reporting company, VERO faces increased scrutiny regarding its ability to fund operations and growth initiatives in the competitive medical instruments sector. The company's primary business involves surgical and medical instruments and apparatus, operating under SIC code 3841. Key risks include market acceptance of its products and the ability to raise capital effectively, as evidenced by the continuous offering structure. The strategic outlook suggests a focus on maintaining operational flexibility and potentially expanding its product lines, though specific details are not provided in this amendment.
Why It Matters
This S-1/A filing signals Venus Concept's intent to maintain capital-raising flexibility, crucial for a smaller reporting company in the competitive surgical and medical instruments market. For investors, it indicates potential dilution from future offerings, impacting share value. Employees and customers may see this as a move to stabilize the company's financial footing, ensuring continued product development and support. The broader market will watch how VERO leverages this flexibility against larger competitors like InMode and Cynosure, which have stronger balance sheets and market penetration.
Risk Assessment
Risk Level: medium — The filing indicates a 'delayed or continuous basis' offering under Rule 415, which inherently carries medium risk due to potential future dilution without immediate clarity on pricing or timing. As a 'smaller reporting company,' VERO faces higher capital market volatility and less access to diverse funding sources compared to larger firms, increasing its reliance on such offerings.
Analyst Insight
Investors should monitor VERO's future capital deployment and the terms of any subsequent offerings closely, as significant dilution could impact current shareholder value. Evaluate the company's operational performance and market position before making new investments, considering the ongoing need for external financing.
Key Numbers
- 2025-07-24 — Filing Date (Date S-1/A was filed with the SEC)
- 333-288215 — Registration No. (SEC registration number for the S-1/A)
- 0001140361-25-027108 — Accession Number (Unique identifier for the SEC filing)
- 877-848-8430 — Business Phone (Contact number for Venus Concept Inc.)
- M2J 4Y8 — Business Zip Code (Location of Venus Concept Inc.'s principal executive offices)
Key Players & Entities
- Venus Concept Inc. (company) — Registrant and filer of S-1/A
- Michael Mandarello (person) — Chief Legal Officer & Head of Strategy & Operations, Agent for Service
- Richard Raymer (person) — Counsel from Dorsey & Whitney LLP
- Dorsey & Whitney LLP (company) — Legal counsel for Venus Concept Inc.
- SEC (regulator) — Securities and Exchange Commission
- Restoration Robotics, Inc. (company) — Former name of Venus Concept Inc. until 2017-11-21
- Rule 415 (regulatory) — Rule governing delayed or continuous offerings
- 333-288215 (regulatory) — Registration Statement number
- 0001409269 (regulatory) — Central Index Key (CIK) for Venus Concept Inc.
- 3841 (regulatory) — Standard Industrial Classification (SIC) Code for Surgical & Medical Instruments & Apparatus
FAQ
What is the purpose of Venus Concept Inc.'s S-1/A filing?
Venus Concept Inc.'s S-1/A filing on July 24, 2025, is an amendment to its registration statement for a delayed or continuous offering of securities pursuant to Rule 415 under the Securities Act of 1933. This allows the company flexibility to raise capital over time.
Who is the agent for service for Venus Concept Inc. in this filing?
Michael Mandarello, Chief Legal Officer & Head of Strategy & Operations at Venus Concept Inc., is listed as the agent for service. His contact information is 235 Yorkland Blvd., Suite 900, Toronto, Ontario M2J 4Y8, with a phone number of (877) 848-8430.
What is Venus Concept Inc.'s primary business according to its SIC code?
Venus Concept Inc.'s primary business falls under Standard Industrial Classification (SIC) Code 3841, which corresponds to Surgical & Medical Instruments & Apparatus. This indicates their focus on developing and manufacturing medical devices.
What is the potential impact of a continuous offering on Venus Concept Inc. shareholders?
A continuous offering under Rule 415 means Venus Concept Inc. can issue new shares over time, which could lead to dilution for existing shareholders. Investors should monitor the terms and timing of any future offerings to assess the impact on their investment.
When was Venus Concept Inc. formerly known as Restoration Robotics, Inc.?
Venus Concept Inc. was formerly known as Restoration Robotics, Inc. until November 21, 2017. Prior to that, it was also known as Restoration Robotics Inc. until August 8, 2007.
Where are Venus Concept Inc.'s principal executive offices located?
Venus Concept Inc.'s principal executive offices are located at 235 Yorkland Blvd, Suite 900, Toronto, Ontario M2J 4Y8. Their business phone number is (877) 848-8430.
Is Venus Concept Inc. considered a large accelerated filer?
No, the filing indicates that Venus Concept Inc. is not a large accelerated filer, an accelerated filer, or an emerging growth company. It is likely a smaller reporting company, which is a common designation for companies of its size and market capitalization.
What legal firm is assisting Venus Concept Inc. with this S-1/A filing?
Dorsey & Whitney LLP, with Richard Raymer as counsel, is assisting Venus Concept Inc. with this S-1/A filing. Their office is located at 66 Wellington St. W, Suite 3400, Toronto, ON M5K 1E6, Canada.
What is the significance of the 'delayed or continuous basis' checkbox in the S-1/A?
The checked box for 'delayed or continuous basis pursuant to Rule 415' signifies that Venus Concept Inc. intends to offer securities over an extended period rather than in a single, immediate offering. This provides the company with flexibility to access capital markets as needed.
What is the Central Index Key (CIK) for Venus Concept Inc.?
The Central Index Key (CIK) for Venus Concept Inc. is 0001409269. This unique identifier is used by the SEC to track all filings made by the company.
Risk Factors
- Continuous Offering for Future Capital Needs [medium — financial]: The company has filed an S-1/A for a delayed or continuous offering of securities under Rule 415. This indicates a strategic need to secure future capital, suggesting potential funding gaps or a proactive approach to maintain financial flexibility in a competitive market.
- Market Acceptance of Products [medium — market]: As a company in the medical instruments sector, Venus Concept Inc. faces the risk of market acceptance for its surgical and medical instruments and apparatus. Failure to gain traction or compete effectively could impact revenue and growth prospects.
Industry Context
Venus Concept Inc. operates in the competitive medical instruments sector, specifically focusing on surgical and medical instruments and apparatus (SIC 3841). This industry is characterized by rapid technological advancements, stringent regulatory requirements, and the need for continuous innovation to maintain market share. Companies in this space often rely on effective capital raising to fund research and development, manufacturing, and market expansion.
Regulatory Implications
As a registrant with the SEC and a participant in the medical device industry, Venus Concept Inc. is subject to various regulatory requirements. The S-1/A filing itself is a regulatory process. Furthermore, the company's products will likely be subject to oversight by health authorities, such as the FDA in the United States, requiring adherence to safety and efficacy standards.
What Investors Should Do
- Monitor Future Filings for Financial Updates
- Evaluate Product Pipeline and Market Adoption
- Assess Capital Structure and Debt Levels
Key Dates
- 2025-07-24: Filing of S-1/A Amendment — Indicates the company is preparing for or actively seeking to raise capital through a continuous offering, signaling a need for financial flexibility.
- 2017-11-21: Name Change from Restoration Robotics, Inc. — Marks a significant corporate identity change, potentially reflecting a shift in business focus or strategy.
- 2007-08-08: Previous Name Change from Restoration Robotics Inc — Indicates a history of corporate restructuring or rebranding prior to the current entity.
Glossary
- S-1/A
- An amendment to a registration statement filed with the SEC, used to update or correct information previously submitted. (This filing indicates Venus Concept Inc. is amending its registration statement, likely to provide updated information or to facilitate a continuous offering.)
- Rule 415
- SEC rule that permits 'at-the-market' or continuous offerings of securities over a period of time. (The company is utilizing Rule 415, signifying its intention to offer securities on a delayed or continuous basis to secure future capital flexibly.)
- Smaller Reporting Company
- A company that meets certain criteria regarding public float and revenue, allowing for scaled disclosure requirements. (Venus Concept Inc. is identified as a smaller reporting company, which may affect the level of detail and scrutiny in its SEC filings.)
- SIC Code 3841
- Standard Industrial Classification code for Surgical & Medical Instruments & Apparatus. (This code categorizes Venus Concept Inc.'s primary business, placing it within the medical device manufacturing industry.)
Year-Over-Year Comparison
This S-1/A filing on July 24, 2025, is an amendment to a registration statement, indicating a strategic move for continuous capital raising under Rule 415. Unlike a typical annual or quarterly report, it does not provide updated financial metrics like revenue or net income compared to a prior period. The primary focus is on the mechanism for future financing rather than a review of past performance. New risks highlighted likely pertain to the execution of this continuous offering and ongoing market dynamics.
Filing Details
This Form S-1/A (Form S-1/A) was filed with the SEC on July 24, 2025 by Michael Mandarello regarding Venus Concept Inc. (VERO).